Biophotonics Market Regional Outlook, Competitive Strategies & Forecast by 2027
North America is forecast to grow at a
CAGR of 11.2% during the predicted span due to the growing investment in the
R&D sector and the increasing cancer occurrences in the region. The
augmented healthcare infrastructure development and expenditure coupled with
growing initiatives from the government are anticipated to accelerate the
market's growth in the area.
The Global Biophotonics Market is
anticipated to garner a valuation of USD 118.19 Billion by 2027, growing at a
CAGR of 11.7%, as per the latest analysis by Emergen Research.
To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/biophotonics-market
Key players of the industry include
Affymetrix, Inc., Zecotek Photonics Inc., Andor Technology Ltd, FEI Company,
Carl Zeiss AG, Hamamatsu Photonics K.K. Lumenis Ltd., and Becton, Dickinson,
and Company, among others.
For the purpose of this report, Emergen
Research has segmented the Global Biophotonics Market based on technology,
application, end-user and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
·
In-vitro
·
In-vivo
Application Outlook (Revenue, USD Billion; 2017-2027)
·
Light Therapy
·
Microscopy
·
Endoscopy
·
Surface Imaging
·
Spectromolecular
·
Biosensors
End-User Outlook (Revenue, USD Billion; 2017-2027)
·
Medical Therapeutics
·
Medical Diagnostics
·
Test Components
Regional Outlook (Revenue: USD Billion; 2017-2027)
·
North America
o U.S.
o Canada
o Mexico
·
Europe
o U.K.
o Germany
o France
o BENELUX
o Rest of Europe
·
Asia Pacific
o China
o Japan
o South Korea
o Rest of APAC
·
Latin America
o Brazil
o Rest of LATAM
·
Middle East & Africa
o Saudi Arabia
o U.A.E.
o
Rest of MEA
Comments
Post a Comment